Differences in adverse events between 250mg daily gefitinib and 150mg daily erlotinib in Japanese patients with non-small cell lung cancer

✍ Scribed by Togashi, Yosuke; Masago, Katsuhiro; Fujita, Shiro; Hatachi, Yukimasa; Fukuhara, Akiko; Nagai, Hiroki; Sakamori, Yuichi; Kim, Young Hak; Mio, Tadashi; Mishima, Michiaki

• Book ID: 119320550
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 182 KB
• Volume: 74
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/j.lungcan.2011.01.022